[1]
“PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS”, scholar, vol. 8, no. 2.2, Sep. 2019, Accessed: Mar. 09, 2025. [Online]. Available: https://jconsortium.com/index.php/scholar/article/view/93